Skip to main content
Log in

Effects of anti-estrogens on bone in castrated and intact female rats

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The effects of the antiestrogens tamoxifen and keoxifene on the bone density of intact and ovariectomized female rats were determined after 4 months of therapy. The antiestrogens did not cause a decrease in bone density in intact animals, although uterine wet weight did decrease. Ovariectomy caused an increase in body weight (25%) and a significant decrease in femur density (P<0.01). Antiestrogens did not further decrease the bone density of ovariectomized rats but rather helped to maintain bone density. Antiestrogens as well as estrogen (oral estradiol benzoate 25µg daily) helped to maintain bone density in the range observed for the intact rats, but inhibited estrogen stimulation of uterine weight. These contrasting pharmacological actions of antiestrogens suggest that patients receiving long-term adjuvant tamoxifen therapy for breast cancer should be evaluated to determine whether tamoxifen can retard the development of osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Furr BJ, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25: 127–205, 1984

    PubMed  Google Scholar 

  2. Legha SS, Carter SK: Antiestrogens in the treatment of breast cancer. Cancer Treat Rev 3: 205–215, 1976

    PubMed  Google Scholar 

  3. Fisher B, Redmond C, Brown A, Wolmark N, Wittliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R: Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med 305: 1–6, 1981

    PubMed  Google Scholar 

  4. Baum M, and other members of the Nolvadex Adjuvant Trial Organization: Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Lancet i: 836–840, 1985

    Google Scholar 

  5. Cummings FJ, Gay R, Davis TE, Tormey DC, Harris JE, Falkson G, Arseneau J: Adjuvant tamoxifen treatment of eldery women with stage II breast cancer. A double-blind comparison with placebo. Annals Int Med 103: 324–329, 1985

    Google Scholar 

  6. Tormey DC, Jordan VC: Long-term adjuvant therapy in node positive breast cancer. A metabolic and pilot clinical study. Breast Cancer Res Treat 4: 297–302, 1984

    PubMed  Google Scholar 

  7. Tormey DC, Rasmussen P, Jordan VC: Update on longterm tamoxifen study. Breast Cancer Res Treat 9: 157–158, 1987

    PubMed  Google Scholar 

  8. Jordan VC: Tamoxifen prophylaxis: prevention is better than cure — prevention is cure? In: Cavalli F (ed) Endocrine Therapy of Breast Cancer: Concepts and Strategies. European School of Oncology Monograph, 1986, pp 117–120

  9. Lindsay R, Hart DM, Forrest C, Baird C: Prevention of spinal osteoporosis in oophorectomized women. Lancet ii: 1151–1153, 1980

    Google Scholar 

  10. Beall PT, Misra KL, Young RL, Spjut HJ, Evan HJ, LeBlanc A: Clomiphene protects against osteoporosis in the mature ovariectomized rat. Calcif Tissue Int 36: 123–125, 1985

    Google Scholar 

  11. Clark JH, Markaverich BN: The agonist-antagonistic properties of clomiphene: a review. Pharmacol Ther 15: 467–519, 1982

    Google Scholar 

  12. Black LJ, Jones CD, Falcone JF: Antagonism of estrogen action with a new benzothiophene-derived antiestrogen. Life Sci 32: 1031–1036, 1983

    PubMed  Google Scholar 

  13. Gottardis MM, Jordan VC: The antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res 47: 4020–4024, 1987

    PubMed  Google Scholar 

  14. Suda T, DeLuca HF, Tanaka Y: Biological activity of 25-hydroxyergocalciferol in rats. J Nutr 100: 1049–1052, 1970

    PubMed  Google Scholar 

  15. Saville PD: Changes in skeletal mass and fragility with castration in the rat: a model of osteoporosis. J Am Geriatr Soc 17: 155–166, 1969

    PubMed  Google Scholar 

  16. Lingren JU, Lindholm TS: Effect of 1-alpha-hydroxy vitamin D3 on osteoporosis in rats induced by oophorectomy. Calcif Tissue Int 27: 161–164, 1979

    PubMed  Google Scholar 

  17. Wade GN, Zucker I: Development of hormonal control over food intake and body weight in female rats. J Comp Phys Psychol 70: 213–220, 1970

    Google Scholar 

  18. Jordan VC, Dowse LJ: Tamoxifen as an antitumor agent: effect on oestrogen binding. J Endocrinol 68: 247–303, 1976

    Google Scholar 

  19. Aitken JM, Armstrong E, Anderson JB: Osteoporosis after oophorectomy in the mature female rat and the effect of estrogen and/or progestogen replacement therapy in its prevention. J Endocrinol 55: 79–87, 1972

    PubMed  Google Scholar 

  20. Gusberg S: Hormone dependence of endometrial cancer. Obstet Gynecol 30: 287–293, 1967

    PubMed  Google Scholar 

  21. Swenerton KD: Treatment of advanced endometrial carcinoma with tamoxifen. Cancer Treat Rep 64: 805–808, 1980

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jordan, V.C., Phelps, E. & Lindgren, J.U. Effects of anti-estrogens on bone in castrated and intact female rats. Breast Cancer Res Tr 10, 31–35 (1987). https://doi.org/10.1007/BF01806132

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806132

Key words

Navigation